We report 2 cases of disseminated cryptococcosis with central nervous system involvement
in patients with chronic lymphoid malignancies occurring within 1 month of starting on …

Cryptococcus is a unique environmental fungus that can cause disease most often in
immunocompromised individuals with defective cell‐mediated immunity. Chronic …

Cryptococcal infections are responsible for significant morbidity and mortality in
immunocompromised patients. Reports of these infections in patients on small molecular …

Purpose Invasive fungal diseases and especially Cryptococcus neoformans infections are
increasingly reported in patients with hematological malignancies receiving ibrutinib, a …

Infectious complications are a major cause of morbidity and mortality in indolent
lymphoproliferative disease patients [1]. The pathogenesis of infections is related to both …

Chronic lymphocytic leukemia (CLL) is a disorder of B cells that affects humoral as well as
cell-mediated immunity. Protection against cryptococcal infections is mounted by an intricate …

We read with great interest the article from Peri et al. describing a case report of invasive 26
aspergillosis (IA) with primary pulmonary involvement followed by central nervous system 27 …

We report a case of Cryptococcus neoformans pulmonary infection complicated by
empyema in a 79-year-old man with diffuse large B-cell lymphoma treated with R-CHOP and …

Abstract Background Ibrutinib is a Bruton tyrosine kinase inhibitor that is used for the
treatment of lymphoid cancers, including chronic lymphocytic leukemia, Waldenström …

Ibrutinib is a novel oral covalent inhibitor of Bruton's tyrosine kinase (BTK). It has been
approved for the treatment of relapsing chronic lymphocytic leukemia (CLL), or CLL with …